ArticleThe World Allergy Organization journal2024

Safety of 300IR house dust mite sublingual tablet from pooled clinical trial and post-marketing data.

Margitta Worm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.